About
Dennis Wahr, M.D. joined Holaira in September 2012, with a unique background in serial medical device development, clinical evaluation and commercialization experience. Prior to joining Holaira, Dr. Wahr co-founded Lutonix in 2007 and served as its President and CEO until CR Bard acquired the company in December 2011. Preceding its acquisition, Lutonix developed a unique drug coated balloon angioplasty technology for the treatment and prevention of vascular stenosis caused by atherosclerosis. Prior to Lutonix, Dr. Wahr co-founded Velocimed in 2001, and served as its President and CEO until its acquisition by St. Jude Medical in 2005. As a company CEO, Dr. Wahr has wide-ranging experience with both the European regulatory authorities and the US FDA. His companies have sponsored 9 clinical trials involving more than 1500 patients leading to approvals for 4 unique and innovative medical products. Dr. Wahr has served on the board of directors of several medical device companies includi
Position in the VCSift Database
- • 1 investors hold the Board of Directors, President & CEO role in VCSift. Dennis W. Wahr is one of them.
- • 365 investors are based in Minneapolis, Minnesota, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Minneapolis, US
Contact Information
Find more investors like Dennis
Search Investors